Trial Summary
The studies on MyoCI training for stroke recovery do not report any safety concerns, suggesting it is generally safe for human use.
34567MyoCI is unique because it uses a myoelectric computer interface to provide feedback on muscle activation patterns, helping stroke survivors reduce abnormal muscle co-activation and improve arm movement. This approach focuses on retraining muscle activation patterns, which is different from traditional physical therapies that may not specifically target muscle co-activation.
23467Research shows that Myoelectric Computer Interface (MyoCI) training helps stroke survivors improve arm function by reducing abnormal muscle co-activation, which is a common issue after a stroke. Studies found that participants who underwent MyoCI training experienced improvements in arm movement and function, suggesting that this treatment could be beneficial for stroke recovery.
12346The trial does not specify if you need to stop taking your current medications, but it does exclude those who have had spasticity treatment with medications or Botox in the last 3 months.
Eligibility Criteria
This trial is for chronic stroke survivors aged 21 or older with severe to moderate arm motor impairment, who had their first stroke at least 6 months ago. Participants must have some voluntary shoulder and elbow movement but can't join if they have ferromagnetic implants, are in other studies, struggle with English due to aphasia, suffer from substantial pain or visual impairments that affect screen viewing, or have received spasticity treatment recently.Inclusion Criteria
Exclusion Criteria